Market Place
Sourcing Support
Formosa Labs Q3 Earnings: NT$0.19 EPS Vs NT$0.95 Loss In 2023
18 Nov 2024 //
PRESS RELEASE
Formosa Labs Passes FDA Inspection For Breast Cancer Drug
19 Sep 2024 //
PRESS RELEASE
Formosa Passes 1st FDA GMP Check For High-Potency Injectables
16 Sep 2024 //
PRESS RELEASE
Formosa Pharma Licenses Clobetasol Ophthalmic Drug To Apotex
05 Sep 2024 //
PRESS RELEASE
Formosa Labs Completes Acquisition of Synchem
04 Jun 2024 //
CONTRACT PHARMA
Formosa Acquires Synchem, Expands North American CDMO Footprint
03 Jun 2024 //
PR NEWSWIRE
HCmed, Formosa Lab, and Formosa Pharma Signed MoU to Form a Global CDMO
06 Mar 2022 //
PRNEWSWIRE
Brazil Sets Anti-Dumping Tariffs On Chemical Firms
13 Apr 2015 //
TAIPEI TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.